Binding Affinities and Non-Bonded Interaction Energies

Perspectives in Drug Discovery and Design

Volumn 9, Issue , 1998, Pages 99-114

  Knegtel, Ronald M A ^a   Grootenhuis, Peter D J ^a  

^a NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003146950     PISSN: 09282866     EISSN: None     Source Type: Journal    
DOI: 10.1007/0-306-46857-3_6     Document Type: Article

References (54)

1. Janin, J., Elusive affinities, Proteins: Struct. Funct. Genet., 21 (1995) 30-39.
2. Ajay and Murcko, M.A., Computational methods to predict binding free energy in ligand-receptor complexes, J. Med. Chem., 38 (1996) 4953-4967.
3. Böhm, H.-J. and Klebe, G., What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs?, Angew. Chem. Int. Ed. Engl. 35 (1996) 2588-2614.
4. Verlinde, C.L.M.J. and Hol, W.G.J., Structure-based drug design: Progress, results and challenges, Structure, 2 (1994) 577-587.
5. Böhm, H.-J., Current computational tools for de novo ligand design, Curr. Opin. Biotech., 7 (1996) 433-436.
6. Clark, M., Cramer. R.D., III, Jones, D.M., Patterson, D.E. and Simeroth, P.E., Comparative molecular field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc., 110 (1988) 5959-5967.
7. Clark. M., Cramer, R.D., III, Jones, D.M., Patterson, D.E. and Simeroth, P.E., Comparative molecular field analysis (CoMFA): 2. Towards its use with 3D-structural databases, Tetrahedron Comput. Methodol., 3 (1990) 47-59.
8. Grootenhuis, P.D.J. and van Helden, S.P., Rational approaches towards protease inhibition: Predicting the binding of thrombin inhibitors, In Wipff, G. (Ed.) Computational approaches in supramolecular chemistry, Kluwer Academic Publishers, Dordrecht (N1), 1994, 137-149.
9. Perakyla, M. and Pakkanen, T. A., Model assembly study of the ligand binding by p-hydroxybenzoate hydroxylase: Correlation between the calculated binding energies and the experimental dissociation constants, Proteins: Struct. Funct. Genet., 21 (1995) 22-29.
10. Cramer, C.J. and Truhlar, D.G., Continuum solvation models: Classical and quantum mechanical implementations, In Lipkowitz, K.B. and Boyd, D.B. (Eds.) Reviews in computational chemistry, 6, VCH Publishers Inc., New York, 1995, pp. 1-72.
11. Kollman,P., Free energy calculations: Applications to chemical and biochemical phenomena, Chem. Rev., 93 (1993) 2395-2417.
12. Rao, B.G., Tilton, R.F. and Singh. U.C., Free energy perturbation studies on inhibitor binding to HIV-1 proteinase. J. Am. Chem. Soc., 114 (1992) 4447-4452.
13. Aqvist, J. and Mowbray, S.L., Sugar recognition by a glucose/galactose receptor: Evaluation of binding energetics from molecular dynamics simulations. J. Biol. Chem., 270 (1995) 9978-9981.
14. Liu, H.Y., Mark, A.E. and van Gunsteren, W.F., Estimating the relative free energy of different molecular stawtes with respect to a single reference state, J. Phys. Chem., 100 (1996) 9485-9494.
15. Finkelstein, A. V. and Janin, J., The price of lost freedom: Entropy of biomolecular complex formation, Protein Eng., 3 (1989) 1-3.
16. Weiner, S.J., Kollman, P.A., Case, D.A., Singh, U.C., Ghio, C., Alagona, G., Profeta, S. and Weiner, P.K. A new force field for molecular mechanics simulation, J. Am. Chem. Soc., 106 (1984) 765-784.
17. Kuntz, I.D., Blaney, J.M., Oatley, S.J., Langridge, R. and Ferrin, T.E., A geometric approach to macro-molecule-ligand interactions, J. Mol. Biol., 161 (1982) 269-288.
18. DesJarlais, R.L., Sheridan, R.P., Seibel, G.L., Dixon, J.S., Kuntz, I.D. and Venkataraghavan, R., Using shape complementarily as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure, J. Med. Chem. 31 (1988) 722-729.
19. Meng, E.C., Shoichet, B.K. and Kuntz, I.D., Automated docking using grid-based energy evaluation, J. Comp. Chem., 13 (1992) 505-524.
20. Ring, C.S., Sun, E., McKerrow, J.H., Lee. G.K., Rosenthal, P.J., Kuntz, I.D. and Cohen, F.E., Structure-based inhibitor design by using protein models for the development of antiparasitic agents, Proc. Natl. Acad. Sci. USA, 90 (1993) 3583-3587.
21. Grootenhuis, P.D.J. and van Galen, P.J.M., Correlation of binding affinities with non-bonded interaction energies of thrombin-inhibitor complexes, Acta Cryst., D51 (1995) 560-566.
22. Brooks, B., Bruccoleri, R., Olafson, B., States, D., Swaninathan, S. and Karplus, M., Charmm: A program for macromolecular energy minimization and molecular dynamics calculations, J. Comp. Chem., 4 (1983) 187-217.
23. Kurinov, I.V. and Harrison, R.W., Prediction of new serine proteinase inhibitors, Nature Struct. Biol., 1 (1994) 735-743.
24. Rappé, A.K., Casewit, C.J., Colwell, K.S., Goddard, W.A.I. and Skiff, W.M., UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations, J. Am. Chem. Soc., 114 (1992) 10024-10046.
25. Luty, B.A., Wasserman, Z.R., Stouten, P.F.W., Hodge, C.N., Zacharias, M. and McCammon, J.A., A molecular mechanics/grid method for evaluation of ligand-receptor interactions, J. Comp. Chem., 16 (1995) 454-464
26. Viswanadhan, V.N., Reddy, M.R., Wlodawer, A., Varney, M.D. and Weinstein, J.N., An approach to rapid estimation of relative binding affinities of enzyme inhibitors: Application to peptidomimetic inhibitors of the human immunodeficiency virus type 1 protease, J. Med. Chem., 39 (1996) 705-712.
27. Ortiz, A.R., Pisabarro, M.T., Gago, F. and Wade, R.C., Prediction of drug binding affinities by comparative binding energy analysis, J. Med. Chem., 38 (1995) 2681-2691.
28. Mitchell, T.J., An algorithm for the construction of 'D-optimal' experimental designs, Technometrics, 16 (1974) 203-210.
29. Holloway, K.M., Wai, J.M., Halgren, T., Fitzegerald, P.M.D., Vacca, J.P., Dorsey, B.D., Levin, R.B., Thompson, W.J., Chen, L.J., deSolms, S.J., Gaffin, N., Ghosh, A.K., Giuliani, E.A., Graham, S.L., Guare, J.P., Hungate, R.W., Lyle, T.A., Sanders, W.M., Tucker, T.J., Wiggins, M., Wiscount, C.M., Woltersdorf. O.W., Young, S.D., Darke, P.L. and Zugay, J. A., A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site, J. Med. Chem., 38 (1995) 305-317.
30. Babu, Y.S., Ealick, S.E., Bugg, C.E., Erion, M.D., Guida, W.C., Montgomery, J.A. and Secrist, J.A., III, Structure-based design of inhibitors of purine nucleoside phosphorylase, Acta Cryst., D51 (1995) 529-535.
31. Jetten, M., Peters, C.A.M., Visser, A., Grootenhuis, P.D.J., van Nispen, J.W. and Ottenheijm, H.C.J., Peptide-derived transition state analogue inhibitors of thrombin; Synthesis, activity and selectivity, Bioorg. Med. Chem., 3 (1995) 1099-1114.
32. Shen, J. and Wendoloski, J., Electrostatic binding energy calculation using the finite difference solution to the linearized Poisson-Boltzmann equation: Assessment of its accuracy, J. Comp. Chem., 17 (1996) 350-357.
33. Zhang, T. and Koshland, D.E., Jr., Computational method for relative binding energies of enzyme-substrate complexes, Prot. Sci. 5 (1996) 348-356.
34. i, calculations for neuramidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuramidase, Proteins: Struct. Funct. Genet. 23 (1995) 264-277.
35. Zacharias, M., Luty, B.A., Davis, M.E. and McCammon, J.A., Combined conformational search and finite-difference Poisson-Boltzmann approach for flexible docking: Application to an operator mutation in the lambda repressor-operator complex, J. Mol. Biol., 238 (1994) 455-465.
36. Böhm, H.-J., The development of a simple empiric scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure, J. Comput.-Aided Mol. Design, 8 (1994) 243-256.
37. Dougnerty, D.A. and Stauffer, D.A., Acetylcholine binding by a synthetic receptor: Implications for biological recognition, Science, 250 (1990) 1558-1560.
38. Head, R.D., Smythe, M.L., Oprea, T.I., Waller, C.L., Green, S.M. and Marshall, G.R., VALIDATE: A new method for the receptor-based prediction of binding affinities of novel ligands, J. Am. Chem. Soc., 118 (1996) 3959-3969.
39. Verkhivker, G.M., Rejto, P.A., Gehlhaar, D.K. and Freer, ST., Exploring the energy landscapes of molecular recognition by a genetic algorithm: Analysis of the requirements for robust docking of HIV-1 protease and FKBP-12 complexes, Proteins: Struct. Funct. Genet., 250 (1996) 342-353.
40. Knegtel, R.M.A., Rullman, J.A.C., Boelens, R. and Kaptein, R., MONTY: A Monte Carlo approach to protein-DNA recognition, J. Mol. Biol., 235 (1994) 318-324.
41. Jain, A.N., Scoring noncovalent protein-ligand interactions: A continuous differentiable function tuned to compute binding affinities, J. Comput.-Aided Mol. Design, 10 (1996) 427-440.
42. Novotny, J., Bruccoleri, R.E. and Saul, F.A., On the attribution of binding energy in antigen-antibody complex MCPC 603.D1.3 and Hyhel-5, Biochemistry, 28 (1989) 4735-4749.
43. Bohacek, R.S. and McMartin, C. Definition and display of steric, hydrophobic and hydrogen-bonding properties of ligand binding sites in proteins using Lee and Richards ' accessible surface: Validation of a high-resolution graphical tool for drug design, J. Med. Chem., 35 (1992) 1671-1684.
44. Eisenberg, D. and McLachlan, A.D., Salvation energy in protein folding and binding, Nature, 319 (1986) 199-203.
45. Hoton, N. and Lewis, M., Calculation of the free energy of association for protein complexes, Prot. Sci., 1 (1992) 169-181.
46. Krystek, S., Stouch, T. and Novotny, J., Affinity and specificity of serine endopeptidase-protein inhibitor interactions: Empirical free energy calculations based on crystallographic studies, J. Mol. Biol., 234 (1993) 661-679.
47. Vajda, S., Weng, Z., Rosenfeld, R. and DeLisi, C., Effect of conformational flexibility and salvation on receptor-ligand binding free energies, Biochemistry, 33 (1994) 13977-13988.
48. Wallqvist, A., Jernigan, R.L. and Covell, D.G., A preference-based free energy parameterization of enzyme-inhibitor binding: Applications to HIV-1 protease inhibitor design, Prot. Sci., 4 (1995) 1881-1903.
49. Wallqvist, A. and Covell, D.G., Docking enzyme-inhibitor complexes using a preference-based free energy surface, Proteins: Struct. Funct. Genet. 25 (1996) 403-419.
50. Laskowski, R.A., Thornton, J.M., Humblet, C. and Singh, J., X-SITE: Use of empirically derived atom packing preferences to identify favorable interaction regions in the binding sites of proteins, J. Mol. Biol. 259 (1996) 175-201.
51. Verkhivker, G., Appelt, K., Freer, S.T. and Villafranca, J.E., Empirical free energy calculations of ligand-protein cristallographic complexes: 1. Knowledge-based ligand-protein interaction potentials applied to the prediction of human immunodeficiency virus protease 1 binding affinity, Protein Eng. 8 (1995) 677-691.
52. DeWitte, R.S. and Shakhnovich, E.I., SMoG: De novo design method based on simple, fast, and accurate free energy estimates: 1. Methodology and supporting evidence, J. Am. Chem. Soc., 118 (1996) 11733-11744.
53. Moult, J., The current state of the art in protein structure prediction, Curr. Opin. Biotech., 7 (1996) 422-427.
54. Eisenberg, D. Into the black of night, Nature Struct. Biol., 4 (1997) 95-97.